Cabozantinib, sold under the brand names Cometriq and Cabometyx, is an anti-cancer medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It was discovered and developed by Exelixis Inc.
Cabozantinib comes in two forms:
Cometriq (capsules): Used to treat medullary thyroid cancer.
Cabometyx (tablets): Used to treat renal cell carcinoma, hepatocellular carcinoma, and differentiated thyroid carcinoma.
It’s important to note that Cometriq and Cabometyx have different formulations and are not interchangeable.
Cabozantinib Cost:
The cost of Cabozantinib can vary depending on factors such as your location, insurance coverage, and dosage. On average, it can cost several thousand dollars per month. There are other brands of Cabozantinib made in Bangladesh. Cabozantinib price are given below:
Cabanib | |
Formulation: Capsule | |
Pack size: 90 Capsules | |
Strength: 20 mg | |
Price: $190 (USD) | |
Manufacturer: Drug International Ltd |
Caboxen | |
Formulation: Capsule | |
Pack size: 90 Capsules | |
Strength: 20 mg | |
Price: $185 (USD) | |
Manufacturer: Everest Pharmaceuticals Ltd |
Caboxen | |
Formulation: Capsule | |
Pack size: 30 Capsules | |
Strength: 80 mg | |
Price: $225 (USD) | |
Manufacturer: Everest Pharmaceuticals Ltd |
Cabozanix | |
Formulation: Capsule | |
Pack size: 90 Capsules | |
Strength: 20 mg | |
Price: $810 (USD) | |
Manufacturer: Beacon Pharmaceuticals Ltd |
Cabozanix | |
Formulation: Tablet | |
Pack size: 30 Tablets | |
Strength: 60 mg | |
Price: $890 (USD) | |
Manufacturer: Beacon Pharmaceuticals Ltd |
Cabozanix | |
Formulation: Capsule | |
Pack size: 30 Capsules | |
Strength: 80 mg | |
Price: $925 (USD) | |
Manufacturer: Beacon Pharmaceuticals Ltd |
Cabozantinib Mechanism of action, Side Effects & Dosage.